H. S. Friedman

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

H. S. Friedman, R E McLendon, Tracy Kerby et al. · Journal of Clinical Oncology · 1998 · 422 citations · Full text

Medicine, Oncology, Pharmacology +17

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

Peter A. Humphrey, Albert J. Wong, Bert Vogelstein et al. · Proceedings of the National Academy of Sciences · 1990 · 383 citations

Medicine, Molecular Biology, Oncology +17

Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.

Timothy R. DeGrado, S. W. BALDWIN, S Wang et al. · PubMed · 2001 · 334 citations

Medicine, Oncology, Pharmacology +14

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

H. S. Friedman, Demetrius M. Kokkinakis, James M. Pluda et al. · Journal of Clinical Oncology · 1998 · 217 citations · Full text

Medicine, Oncology, Pharmacology +16

Infrequent p53 gene mutations in medulloblastomas.

Robert L. Saylors, David Sidransky, H. S. Friedman et al. · PubMed · 1991 · 190 citations

Life Sciences, Genetics, Oncology +17